PL2121593T3 - Przezskórne systemy dostarczania antybiotyków beta-laktamowych - Google Patents

Przezskórne systemy dostarczania antybiotyków beta-laktamowych

Info

Publication number
PL2121593T3
PL2121593T3 PL06832186T PL06832186T PL2121593T3 PL 2121593 T3 PL2121593 T3 PL 2121593T3 PL 06832186 T PL06832186 T PL 06832186T PL 06832186 T PL06832186 T PL 06832186T PL 2121593 T3 PL2121593 T3 PL 2121593T3
Authority
PL
Poland
Prior art keywords
beta
delivery systems
transdermal delivery
lactam antibiotics
lactam
Prior art date
Application number
PL06832186T
Other languages
English (en)
Inventor
Chongxi Yu
Original Assignee
Chongxi Yu
Priority date (The priority date is an assumption and is not a legal conclusion. Google has not performed a legal analysis and makes no representation as to the accuracy of the date listed.)
Filing date
Publication date
Application filed by Chongxi Yu filed Critical Chongxi Yu
Publication of PL2121593T3 publication Critical patent/PL2121593T3/pl

Links

Classifications

    • C—CHEMISTRY; METALLURGY
    • C07—ORGANIC CHEMISTRY
    • C07D—HETEROCYCLIC COMPOUNDS
    • C07D499/00—Heterocyclic compounds containing 4-thia-1-azabicyclo [3.2.0] heptane ring systems, i.e. compounds containing a ring system of the formula:, e.g. penicillins, penems; Such ring systems being further condensed, e.g. 2,3-condensed with an oxygen-, nitrogen- or sulfur-containing hetero ring
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
    • A61P31/00—Antiinfectives, i.e. antibiotics, antiseptics, chemotherapeutics
    • A61P31/04—Antibacterial agents

Landscapes

  • Chemical & Material Sciences (AREA)
  • Organic Chemistry (AREA)
  • Health & Medical Sciences (AREA)
  • Communicable Diseases (AREA)
  • Oncology (AREA)
  • Chemical Kinetics & Catalysis (AREA)
  • General Chemical & Material Sciences (AREA)
  • Medicinal Chemistry (AREA)
  • Nuclear Medicine, Radiotherapy & Molecular Imaging (AREA)
  • Pharmacology & Pharmacy (AREA)
  • Life Sciences & Earth Sciences (AREA)
  • Animal Behavior & Ethology (AREA)
  • General Health & Medical Sciences (AREA)
  • Public Health (AREA)
  • Veterinary Medicine (AREA)
  • Pharmaceuticals Containing Other Organic And Inorganic Compounds (AREA)
  • Medicines That Contain Protein Lipid Enzymes And Other Medicines (AREA)
  • Medicinal Preparation (AREA)
PL06832186T 2006-12-10 2006-12-10 Przezskórne systemy dostarczania antybiotyków beta-laktamowych PL2121593T3 (pl)

Applications Claiming Priority (2)

Application Number Priority Date Filing Date Title
PCT/IB2006/054724 WO2008072032A1 (en) 2006-12-10 2006-12-10 Transdermal delivery systems of beta-lactam antibiotics
EP06832186.8A EP2121593B1 (en) 2006-12-10 2006-12-10 Transdermal delivery systems of beta-lactam antibiotics

Publications (1)

Publication Number Publication Date
PL2121593T3 true PL2121593T3 (pl) 2015-11-30

Family

ID=39511305

Family Applications (2)

Application Number Title Priority Date Filing Date
PL13161970T PL2656879T3 (pl) 2006-12-10 2006-12-10 Przezskórne układy podania antybiotyków beta-laktamowych
PL06832186T PL2121593T3 (pl) 2006-12-10 2006-12-10 Przezskórne systemy dostarczania antybiotyków beta-laktamowych

Family Applications Before (1)

Application Number Title Priority Date Filing Date
PL13161970T PL2656879T3 (pl) 2006-12-10 2006-12-10 Przezskórne układy podania antybiotyków beta-laktamowych

Country Status (8)

Country Link
US (3) US20100040548A1 (pl)
EP (3) EP2656879B1 (pl)
JP (1) JP5324463B2 (pl)
CN (1) CN101547898B (pl)
CA (1) CA2671938C (pl)
ES (2) ES2547258T3 (pl)
PL (2) PL2656879T3 (pl)
WO (1) WO2008072032A1 (pl)

Families Citing this family (33)

* Cited by examiner, † Cited by third party
Publication number Priority date Publication date Assignee Title
US20090221703A1 (en) 2006-07-09 2009-09-03 Chongxi Yu High penetration composition and uses thereof
US20090238763A1 (en) 2006-07-09 2009-09-24 Chongxi Yu High penetration compositions and uses thereof
EP2091914A4 (en) 2006-11-08 2010-12-29 Chongxi Yu TRANSDERMAL ADMINISTRATION SYSTEMS FOR PEPTIDES AND RELATED CONNECTIONS
EP2656879B1 (en) 2006-12-10 2017-06-28 Chongxi Yu Transdermal delivery systems of beta-lactam antibiotics
WO2008093173A1 (en) 2007-01-31 2008-08-07 Chongxi Yu Positively charged water-soluble prodrugs of 1h-imidazo[4, 5-c]quinolin-4-amines and related compounds with very high skin penetration rates
JP2010529101A (ja) 2007-06-04 2010-08-26 テックフィールズ インコーポレイテッド 非常に速い皮膚及び膜浸透速度を有するｎｓａｉａプロドラッグ及びその新規医薬使用
US20100062042A1 (en) * 2008-07-15 2010-03-11 Basf Catalysts Llc Methods, Systems and Devices for Administration of Chlorine Dioxide
CN108191846B (zh) 2008-12-04 2021-08-20 于崇曦 高穿透性组合物及其应用
US20100196512A1 (en) 2009-02-04 2010-08-05 Basf Catalyst Llc Treatment of Non-Oral Biological Tissue with Chlorine Dioxide
EP2660247A3 (en) * 2009-05-08 2014-09-03 Chongxi Yu High penetration prodrug compositions of peptides and peptide-related compounds
CN102803211B (zh) * 2009-06-10 2016-01-27 上海泰飞尔生化技术有限公司 具有高穿透性的抗微生物剂和抗微生物剂相关化合物的前药组合物
EP2440523A4 (en) * 2009-06-10 2014-03-19 Chongxi Yu COMPOSITION WITH STRONG PENETRATION OR PRODRUGS FROM ANTIMICROBIA AND COMPOUNDS IN ANTIMICROBIA
US9969751B2 (en) 2009-06-10 2018-05-15 Techfields Pharma Co., Ltd. High penetration prodrug compositions of antimicrobials and antimicrobial-related compounds
TWI496577B (zh) * 2010-06-10 2015-08-21 Shanghai Techfields Biochem Co Ltd 抗菌劑和抗菌劑相關化合物的高滲透性前藥組合物
EP2704694A4 (en) * 2011-05-02 2014-11-19 Aptalis Pharmatech Inc RAPID DISSOLUTION TABLET COMPOSITIONS FOR VAGINAL DELIVERY
HK1207562A1 (en) 2012-01-18 2016-02-05 苏州泰飞尔医药有限公司 High penetration prodrug compositions and pharmaceutical composition thereof for treatment of pulmonary conditions
US8476425B1 (en) 2012-09-27 2013-07-02 Cubist Pharmaceuticals, Inc. Tazobactam arginine compositions
JP5795343B2 (ja) * 2013-01-23 2015-10-14 チョンシー ユー β−ラクタム抗生物質の経皮送達システム
US20140275000A1 (en) 2013-03-15 2014-09-18 Cubist Pharmaceuticals, Inc. Ceftolozane pharmaceutical compositions
KR102329764B1 (ko) 2013-03-15 2021-11-23 머크 샤프 앤드 돔 코포레이션 세프톨로잔 항균성 조성물
US9872906B2 (en) 2013-03-15 2018-01-23 Merck Sharp & Dohme Corp. Ceftolozane antibiotic compositions
US10376496B2 (en) 2013-09-09 2019-08-13 Merck, Sharp & Dohme Corp. Treating infections with ceftolozane/tazobactam in subjects having impaired renal function
US8906898B1 (en) 2013-09-27 2014-12-09 Calixa Therapeutics, Inc. Solid forms of ceftolozane
CN103539802B (zh) * 2013-10-15 2016-04-27 湖北美天生物科技有限公司 一种喷沙西林氢碘酸盐的合成方法
WO2018090004A2 (en) * 2016-11-14 2018-05-17 The University Of North Carolina At Chapel Hill Tuberculosis therapeutic compounds and methods
CN111801013B (zh) * 2018-03-02 2021-12-24 俄勒冈健康科学大学 小分子核受体调节剂的酰胺前药
EP3894383A1 (en) 2018-12-12 2021-10-20 Autobahn Therapeutics, Inc. Novel thyromimetics
CA3130371A1 (en) 2019-03-01 2020-09-10 Autobahn Therapeutics, Inc. Novel thyromimetics
CN115279359A (zh) 2019-11-29 2022-11-01 速通医疗公司 新型拟甲状腺素药
EP4168384A4 (en) 2020-06-17 2024-07-10 Autobahn Therapeutics, Inc. THYROMIMETICS
EP4167986A4 (en) 2020-06-17 2024-11-20 Autobahn Therapeutics, Inc. THYROMIMETICS
EP4262860A4 (en) 2020-12-17 2025-11-12 Idexx Lab Inc DETECTION AND TREATMENT OF ROCKY MOUNTAIN SPRINKLE FEVER
AU2022271304A1 (en) 2021-05-06 2023-11-23 Autobahn Therapeutics, Inc. Fatty acid amide hydrolase (faah) cleavable prodrugs of thyromimetics and combination with peripherally restricted faah inhibitors

Family Cites Families (63)

* Cited by examiner, † Cited by third party
Publication number Priority date Publication date Assignee Title
US2694061A (en) * 1949-07-07 1954-11-09 Leo Pharm Prod Ltd Method of producing aminoalcohol esters of penicillin
US2694031A (en) * 1949-07-07 1954-11-09 Leo Pharm Prod Ltd Hydroiodides of amino esters of penicillin and oil composition thereof
DE858699C (de) * 1949-07-07 1952-12-08 Leo Pharm Prod Ltd Verfahren zur Herstellung von Estern des Penicillins mit substituierten Aminoalkoholen bzw. deren Salzen oder quaternaeren Ammoniumverbindungen
US2694063A (en) * 1949-07-07 1954-11-09 Leo Pharm Prod Ltd Quaternary ammonium addition salts of penicillin esters
US2593852A (en) 1949-11-16 1952-04-22 Bristol Lab Inc Penicillin amides
GB759603A (en) 1952-07-10 1956-10-24 Yvan Villax Method for the production of esters of penicillin
GB768347A (en) * 1953-02-06 1957-02-13 Knud Abildgaard Sulphanilate salts of amino alcohol esters of penicillin
US3957764A (en) * 1969-11-11 1976-05-18 Lovens Kemiske Fabrik Produktionsaktieselskab 6-aminopenicillanic acid derivatives
CA996929A (en) * 1971-04-05 1976-09-14 Kohzi Nakano Acyloxyalkyl ester derivatives of penicillin
GB1335317A (en) 1971-06-23 1973-10-24 Leo Pharm Prod Ltd Cephalosporin esters salts thereof and methods for their pre paration
ES409580A1 (es) * 1972-12-13 1975-12-01 Andreu Sa Dr Procedimiento para la obtencion de esteres alquilaminoal- quilicos de la alfa-aminobencilpenicilina.
GB1482910A (en) 1973-11-23 1977-08-17 Mercer Ltd F B Commodity packaging
IT1048274B (it) 1974-03-02 1980-11-20 Farmaceutici Italia Esteri di penicilline e di cefauosporine
ES428213A1 (es) * 1974-07-12 1976-07-16 Andreu Sa Dr Procedimiento para la obtencion de esteres dialquilaminoal-quilicos de penicilina.
US4150157A (en) 1976-06-11 1979-04-17 Beecham Group Limited Penicillin compositions
GB1569421A (en) * 1976-06-11 1980-06-18 Beecham Group Ltd Penicillin compositions
GB1578730A (en) 1976-06-24 1980-11-05 Beecham Group Ltd Esters of penicillin antibiotics
US4215120A (en) 1977-07-14 1980-07-29 Beecham Group Limited Penicillin esters and their preparation
IL58939A (en) 1978-12-18 1983-03-31 Meiji Seika Kaisha 7 alpha-methoxycephalosporin derivatives and their production
US4311706A (en) 1980-01-22 1982-01-19 Interx Research Corporation Novel dopa/dopamine prodrugs
JPS5852291A (ja) 1981-09-22 1983-03-28 Kureha Chem Ind Co Ltd ペニシリン系抗生物質誘導体とその医薬剤
JPS58126846A (ja) * 1982-01-22 1983-07-28 Kaken Pharmaceut Co Ltd プロピオン酸アミノアルキルエステル誘導体、その製法およびそれを有効成分とする消炎、鎮痛剤
US4428935A (en) 1982-05-24 1984-01-31 Pfizer Inc. Penicillanic acid dioxide prodrug
JPS59128392A (ja) 1982-12-29 1984-07-24 Kureha Chem Ind Co Ltd セフアロスポリン誘導体及び該誘導体を含有する薬剤
FR2542998B1 (fr) 1983-03-24 1986-01-31 Rhone Poulenc Sante Nouvelle forme transdermale du dinitrate d'isosorbide
DE3347128A1 (de) 1983-12-22 1985-07-11 Schering AG, 1000 Berlin und 4709 Bergkamen 9-halogen-(delta)(pfeil hoch)2(pfeil hoch)-prostaglandinderivate, verfahren zu ihrer herstellung und ihre verwendung als arzneimittel
GB2157284B (en) 1984-04-11 1987-11-04 Leo Pharm Prod Ltd 6-b-halopenicillanic acid salts
JPH01131181A (ja) * 1986-10-02 1989-05-24 Asahi Chem Ind Co Ltd ３−アルコキシメチルセファロスポリン類の製造方法
EP0262744B1 (en) 1986-10-02 1994-03-23 Asahi Kasei Kogyo Kabushiki Kaisha A process for preparing 3-alkoxymethylcephalosphorins
US5321020A (en) * 1989-03-28 1994-06-14 Pfizer Inc. Antibacterial 2-carbapenem derivatives
JP2672363B2 (ja) 1989-03-29 1997-11-05 帝人株式会社 有機非線形光学材料
DE69224294T2 (de) 1991-10-16 1998-08-20 Richardson Vicks Inc Verbesserte hautpenetrationssysteme fuer erhoehte topische freisetzung von arzneimitteln
US5629019A (en) * 1992-02-27 1997-05-13 Alza Corporation Formulations with hydrophobic permeation enhancers
JP2000510842A (ja) * 1996-05-10 2000-08-22 ファルマシア・アンド・アップジョン・カンパニー 全身性細菌疾患の治療のための抗菌剤の局所投与
US5929086A (en) 1996-05-10 1999-07-27 Pharmacia & Upjohn Company Topical administration of antimicrobial agents for the treatment of systemic bacterial diseases
US6011049A (en) 1997-02-19 2000-01-04 Warner-Lambert Company Combinations for diabetes
SE9900941D0 (sv) 1998-12-23 1999-03-16 Nomet Management Serv Bv Novel retinoic acid derivatives and their use
US6417207B1 (en) 1999-05-12 2002-07-09 Nitromed, Inc. Nitrosated and nitrosylated potassium channel activators, compositions and methods of use
US6908900B2 (en) 2001-01-17 2005-06-21 Zimmer & Associates Ag Compositions and methods for enhanced pharmacological activity through oral and parenteral administration of compositions comprising polypeptide drug substances and other poorly absorbed active ingredients
WO2003022270A1 (en) 2001-09-13 2003-03-20 Noven Pharmaceuticals, Inc. Transdermal administration of an enalapril ester
CN100360502C (zh) 2002-07-23 2008-01-09 阿登尼亚投资有限公司 视黄醇衍生物、它们在治疗癌症和增强其它细胞毒性剂功效中的应用
BRPI0408223A (pt) 2003-03-12 2006-03-01 Celgene Corp composto, isÈmeros, composição farmacêutica, e, métodos de inibir pde4 e mmp, de modular a produção de tnf-alfa em um mamìfero e de tratar, previnir ou controlar uma doença ou condição
US7052715B2 (en) 2003-04-11 2006-05-30 All Natural Fmg, Inc. Alcohol-free transdermal analgesic composition and processes for manufacture and use thereof
DE102004025324A1 (de) 2004-05-19 2005-12-08 Boehringer Ingelheim Vetmedica Gmbh Flüssige Zubereitung für die Veterinärmedizin, Verfahren zu deren Herstellung und deren Verwendung
US7074775B2 (en) 2004-09-14 2006-07-11 Miller Landon C G Aminobutyramide conjugate and a pharmaceutical composition for treatment of neuronal disorders
US20060222692A1 (en) * 2005-03-31 2006-10-05 Fairfield Clinical Trials Llc Method and compositions for transdermal administration of antimicrobial medications
KR101446813B1 (ko) 2006-04-06 2014-10-01 뉴파쎄 인크. 도파민 연관된 상태의 치료를 위한 이식체
AU2006346195B2 (en) 2006-07-09 2013-03-07 Techfields Biochem Co. Ltd Positively charged water-soluble prodrugs of aspirin
HUE033687T2 (en) 2006-07-18 2017-12-28 Techfields Biochem Co Ltd Ibuprofen positively charged water soluble prodrugs with very fast skin penetration rates
PL2046727T3 (pl) 2006-07-25 2014-08-29 Techfields Biochem Co Ltd Dodatnio naładowane rozpuszczalne w wodzie proleki diklofenaku o bardzo szybkim stopniu przenikania przez skórę
CN101500983B (zh) 2006-07-26 2015-09-16 于崇曦 具有快速皮肤穿透速度的带正电荷的水溶性二氟尼柳及相关化合物的前药
PT2049482E (pt) 2006-08-08 2016-02-24 Techfields Biochem Co Ltd Profármacos solúveis em água carregados positivamente de ácidos aril- e heteroarilacéticos com velocidade de penetração na pele muito rápida
US8458932B2 (en) 2006-08-11 2013-06-11 Alameda Technology, Llc Optical illusion device
EP2054384A4 (en) 2006-08-15 2010-11-03 Techfields Biochem Co Ltd POSITIVELY LOADED WATER-SOLUBLE PRODRUGS OF ARYL AND HETEROARYLPROPIONIC ACIDS WITH A VERY FAST SKIN PUNCHING RATE
WO2008026776A1 (en) 2006-08-31 2008-03-06 Nanocarrier Co., Ltd. Transdermal composition, transdermal pharmaceutical composition and transdermal cosmetic composition comprising polymer micelle encapsulating active ingredient
PL2084132T3 (pl) 2006-09-03 2019-03-29 Techfields Biochem Co. Ltd Dodatnio naładowane rozpuszczalne w wodzie proleki z kwasów n-arylantranilowych z bardzo szybką penetracją skóry
EP3388417A1 (en) 2006-09-03 2018-10-17 Techfields Biochem Co. Ltd Positively charged water-soluble prodrugs of acetaminophen and related compounds with very fast skin penetration rate
EP2084165B1 (en) 2006-10-11 2013-06-12 Techfields Biochem Co. Ltd Positively charged water-soluble prodrugs of oxicams and related compounds with very high skin penetration rate
EP2091914A4 (en) 2006-11-08 2010-12-29 Chongxi Yu TRANSDERMAL ADMINISTRATION SYSTEMS FOR PEPTIDES AND RELATED CONNECTIONS
EP2656879B1 (en) * 2006-12-10 2017-06-28 Chongxi Yu Transdermal delivery systems of beta-lactam antibiotics
WO2008093173A1 (en) 2007-01-31 2008-08-07 Chongxi Yu Positively charged water-soluble prodrugs of 1h-imidazo[4, 5-c]quinolin-4-amines and related compounds with very high skin penetration rates
JP2010529101A (ja) 2007-06-04 2010-08-26 テックフィールズ インコーポレイテッド 非常に速い皮膚及び膜浸透速度を有するｎｓａｉａプロドラッグ及びその新規医薬使用
US9969751B2 (en) * 2009-06-10 2018-05-15 Techfields Pharma Co., Ltd. High penetration prodrug compositions of antimicrobials and antimicrobial-related compounds

Also Published As

Publication number Publication date
JP5324463B2 (ja) 2013-10-23
EP2121593B1 (en) 2015-06-17
JP2010512380A (ja) 2010-04-22
EP2121593A4 (en) 2010-09-08
US20130018029A1 (en) 2013-01-17
ES2633020T3 (es) 2017-09-18
CN101547898A (zh) 2009-09-30
EP3357926A1 (en) 2018-08-08
US20100040548A1 (en) 2010-02-18
ES2547258T3 (es) 2015-10-02
CA2671938A1 (en) 2008-06-19
CN101547898B (zh) 2014-09-24
US20210206782A1 (en) 2021-07-08
EP2121593A1 (en) 2009-11-25
WO2008072032A1 (en) 2008-06-19
EP2656879B1 (en) 2017-06-28
EP2656879A1 (en) 2013-10-30
US10233197B2 (en) 2019-03-19
CA2671938C (en) 2017-10-17
PL2656879T3 (pl) 2017-09-29

Similar Documents

Publication Publication Date Title
PL2656879T3 (pl) Przezskórne układy podania antybiotyków beta-laktamowych
IL200077A0 (en) Transdermal delivery systems
EP2091914A4 (en) TRANSDERMAL ADMINISTRATION SYSTEMS FOR PEPTIDES AND RELATED CONNECTIONS
GB2444395B (en) Delivery devices
GB2444394B (en) Delivery devices
EP2012871A4 (en) TRANSDERMAL PROCEDURES AND SYSTEMS FOR THE RELEASE OF ANTIMIGRAINE COMPOUNDS
IL198893A0 (en) Lipase variants for pharmaceutical use
IL206184A0 (en) Systems and methods for delivery of materials
IL198911A0 (en) Drug delivery
SI2101740T1 (sl) Nov nezlorabljiv farmacevtski sestavek, obsegajoč opiode
AU2007205298A8 (en) Drug combinations
EP2070919A4 (en) SPIROCHINONE COMPOUND AND PHARMACEUTICAL COMPOSITION
ZA200810676B (en) Novel aminoglycoside antibiotics
SI2084270T1 (sl) Izdelava beta - laktam antibiotikov
GB2476731B (en) Delivery devices
EP2114404A4 (en) COMPOUND AND PHARMACEUTICAL COMPOSITION
GB0617222D0 (en) Antibiotics
GB2461433B (en) Delivery devices
AU2006905107A0 (en) Transdermal delivery of anti-inflammatory agents
GB0811401D0 (en) Pharmaceutical composition comprising antibiotics
HK1122543A (en) Unscrambling conveyor
HK1127894A (en) Glucokinase activators
AU2007903316A0 (en) Transdermal delivery of active agents
HK1147205A (en) Delivery of active agents
GB0608210D0 (en) Methods And Devices For Targeted Drug Deposition